市場調查報告書
商品編碼
963974

微結晶質纖維素 (MCC)的全球市場:成長,趨勢,預測(2020年∼2025年)

Microcrystalline Cellulose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

微結晶質纖維素的市場規模在預測期間內預計將以6%以上的年複合成長率成長。帶動市場的主要原因之一是整個世界主要經濟體中製藥行業對微晶纖維素的需求不斷增長。然而微結晶質纖維素高製造成本,妨礙市場成長。

這份報告提供微結晶質纖維素的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,原料·流程·終端用戶產業·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 促進因素
    • 製藥產業的需求提升
    • 其他
  • 阻礙因素
    • 高製造成本
    • 其他
  • 價值鏈分析
  • 波特的五力分析
  • 流程分析

第5章 市場區隔

  • 各原料
    • 樹為主
    • 非以木材為主
  • 各流程
    • 反應性擠壓成型
    • 酵素媒介
    • 蒸氣爆炸
    • 酸水解
  • 各終端用戶產業
    • 製藥
    • 食物
    • 化妝品
    • 其他
  • 各地區
    • 亞太地區
    • 北美
    • 歐洲
    • 南美
    • 中東和非洲

第6章 競爭情形

  • 合併和收購,合資企業,合作,協定
  • Market Share/Ranking Analysis**
  • 主要企業採用的策略
  • 企業簡介
    • Chemfield Cellulose
    • Accent Microcell Pvt. Ltd
    • FMC Corporation
    • Sigachi Industries Pvt. Ltd
    • DuPont
    • MINGTAI CHEMICAL CO. LTD
    • Asahi Kasei Corporation
    • Juku Orchem Pvt. Ltd
    • J. Rettenmaier & Sohne GmbH + Co. KG
    • Huzhou City Linghu Xinwang Chemical Co. Ltd
    • Avantor Performance Materials Inc.
    • DFE Pharma GmbH & Co.KG
    • Blanver
    • Gujarat Microwax Limited
    • FrieslandCampina

第7章 市場機會及趨勢

  • 帆布的內襯黏劑的微結晶質纖維素複合材料的需求提升
  • 其他機會
目錄
Product Code: 69486

The Global Microcrystalline Cellulose Market is projected to register a CAGR of over 6% during the forecast period (2021-2026).

Pharmaceutical and cosmetics are the major end-user industries of microcrystalline cellulose. The ongoing coronavirus (COVID-19) pandemic has altered the face of the beauty industry. As a result of months of consumer lockdowns, international travel bans, and retail business closures, sales, purchases, and usage have fallen across many beauty segments. However, the pharmaceutical industry experienced an increase in production due to the COVID-19 pandemic as the medicines used in hospitals around the world have increased thus increasing the demand for microcrystalline cellulose which is used in the production of drugs. Furthermore, government support in various countries in the pharmaceutical sector is expected positively influence the market studied. For instance, in 2021, in India, the government has approved 19 applications with committed investments of INR 4623.01 crore under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).

  • Over the short term, the growing demand for microcrystalline cellulose from the pharmaceutical industry across significant economies of the world is expected to drive the demand for the market studied.
  • On the flipside, the high manufacturing and production cost of microcrystalline cellulose is expected to hinder the growth of the market studied.
  • The Asia-Pacific region is expected to dominate the market with increasing manufacturing from the pharmaceutical industry in countries like India and China.

Key Market Trends

Increasing Demand from Pharmaceutical Industry

  • Microcrystalline cellulose (MCC) is a pure partially depolymerized cellulose synthesized from α-cellulose precursor (type IB), obtained as a pulp from fibrous plant material, with mineral acids using hydrochloric acid to reduce the degree of polymerization.
  • Microcrystalline cellulose is a commonly used excipient in the pharmaceutical industry. It has excellent compressibility properties and is used in solid dose forms, such as tablets, and is the most widely used direct compression excipient, acting as a strong dry binder, tablet disintegrant, absorbent, filler or diluent, lubricant, and anti-adherent.
  • MCC is widely regarded as the diluent with the best binding properties, and it is one of the most commonly used direct compression binders.
  • It is used as a binder/diluent in both wet granulation and direct compression processes for oral tablet and capsule formulations. It also has lubricant and disintegrant properties, making it ideal for direct tableting.
  • The factors such as disease prevalence, affordability, consumer's attitude, government (and insurance company) policies, and available supply of medicines boost the pharmaceutical industry, which, in turn, increases the demand for microcrystalline cellulose.
  • Global pharmaceutical industry is increasing with growing production in countries such as United States, China and India. India is a prominent and rapidly growing market for pharmaceuticals. It has largest number of US-FDA compliant Pharma plants (more than 262 including APIs) outside of USA and has more than 2000 WHO-GMP approved Pharma Plants, 253 European Directorate of Quality Medicines (EDQM) approved plants with modern state of the art Technology.
  • Moreover, the companies are also planning to invest across the globe amid increasing demand of pharmaceuticals worldwide. For instance, in December 2020, an Indian company, Piramal Pharma Solutions announced its plans to invest USD 32 million to expand its facility in Michigan, the United States, with additional capacity and new capabilities for development and manufacturing of active pharmaceutical ingredients.
  • Hence, owing to the factors mentioned above, the application of microcrystalline cellulose from the pharmaceutical industry is likely to increase during the forecast period.

Asia-Pacific to Dominate the Market

  • The Asia-Pacific region is expected to dominate the market during the forecast period. The rising demand for microcrystalline cellulose from pharmaceutical and cosmetics industries in countries like China and India is expected to drive the demand for microcrystalline cellulose in this region.
  • According to Invest India, the pharmaceutical industry in India is expected to reach USD 65 billion by 2024 and is currently valued at USD 41 billion.
  • The largest producers of microcrystalline cellulose are based in the Asia-Pacific region. Some of the leading companies in the production of microcrystalline cellulose are Sigachi Industries Pvt. Ltd, Huzhou City Linghu Xinwang Chemical Co. Ltd, DuPont, Asahi Kasei Corporation, and J. Rettenmaier & Sohne GmbH + Co. KG, among others.
  • According to L'Oreal data, the global cosmetic market, which is valued at more than EUR 220 billion, grew by more than 5.5% in 2019, with sales from online platforms gaining the highest momentum, of more than 25% during the same year. This growth is majorly spurred on in the Asia-Pacific region by the limitless diversity of consumer aspirations and owing to the continuous innovations in the industry. Asia-Pacific has the highest demand for cosmetics, particularly luxury products. The region accounted for over half of the skincare market.
  • South Korea has one of the world's most exceptional beauty markets. New beauty trends and innovations, featuring sophisticated ingredients and aesthetically-appealing packaging, are constantly on display. The South Korean cosmetics products market was valued at USD 1,578.4 million in 2019, and it is expected to reach USD 1952.05 million by 2025 during the forecast period, 2020-2025.
  • Owing to the factors mentioned above, the market for microcrystalline cellulose in the Asia-Pacific region is projected to grow significantly during the study period.

Competitive Landscape

The microcrystalline cellulose market is partially fragmented in nature, with only a few major players dominating the market. Some of the major companies of the market studied include DuPont, Chemfield Cellulose, Accent Microcell, Sigachi Industries Limited, and DFE Pharma, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand for Microcrystalline Cellulose from Pharmaceutical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 High Manufacturing and Production Cost
    • 4.2.2 Impact of COVID-19 on Cosmetics Industry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Degree of Competition
  • 4.5 Process Analysis

5 MARKET SEGMENTATION

  • 5.1 Source
    • 5.1.1 Wood-based
    • 5.1.2 Non -wood-based
  • 5.2 Process
    • 5.2.1 Reactive Extrusion
    • 5.2.2 Enzyme Mediated
    • 5.2.3 Steam Explosion
    • 5.2.4 Acid Hydrolysis
  • 5.3 End-User Industry
    • 5.3.1 Pharmaceutical
    • 5.3.2 Food
    • 5.3.3 Cosmetics
    • 5.3.4 Other End-User Industries
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 France
      • 5.4.3.4 Italy
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)** /Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Accent Microcell
    • 6.4.2 Asahi Kasei Corporation
    • 6.4.3 Blanver
    • 6.4.4 Chemfield Cellulose
    • 6.4.5 DFE Pharma
    • 6.4.6 DuPont
    • 6.4.7 GUJARAT MICROWAX PVT. LTD.
    • 6.4.8 Huzhou City Linghu Xinwang Chemical Co., Ltd
    • 6.4.9 J. RETTENMAIER & SOHNE GmbH + Co KG
    • 6.4.10 JUKU ORCHEM PVT. LTD.
    • 6.4.11 MINGTAI CHEMICAL CO., LTD
    • 6.4.12 Sigachi Industries Limited
    • 6.4.13 VWR International, LLC (Avantor, Inc.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Growing Demand of Microcrystalline Cellulose Composites as Lining Adhesives for Canvas
  • 7.2 Other Opportunities